Your browser doesn't support javascript.
loading
STAT3 Inhibitor Napabucasin Inhibits Tumor Growth and Cooperates with Proteasome Inhibition in Human Ovarian Cancer Cells.
Liu, Yao; Peng, Xiaolin; Li, Hui; Jiao, Wenhui; Peng, Xin; Shao, Jingrong; Xu, Yanglu; Wang, Ran; Wang, Wei; Kong, Dexin.
Afiliación
  • Liu Y; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Peng X; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Li H; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Jiao W; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Peng X; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Shao J; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Xu Y; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Wang R; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
  • Wang W; Department of Otorhinolaryngology Head and Neck Surgery, Key Laboratory of Auditory Speech and Balance Medicine, Institute of Otolaryngology of Tianjin, Tianjin First Central Hospital, Tianjin 300192, China.
  • Kong D; Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China.
Recent Pat Anticancer Drug Discov ; 16(3): 350-362, 2021.
Article en En | MEDLINE | ID: mdl-33655847
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Benzofuranos / Naftoquinonas / Apoptosis / Proliferación Celular / Factor de Transcripción STAT3 / Puntos de Control de la Fase G2 del Ciclo Celular / Carcinoma Epitelial de Ovario Límite: Female / Humans Idioma: En Revista: Recent Pat Anticancer Drug Discov Asunto de la revista: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Emiratos Árabes Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Benzofuranos / Naftoquinonas / Apoptosis / Proliferación Celular / Factor de Transcripción STAT3 / Puntos de Control de la Fase G2 del Ciclo Celular / Carcinoma Epitelial de Ovario Límite: Female / Humans Idioma: En Revista: Recent Pat Anticancer Drug Discov Asunto de la revista: NEOPLASIAS / TERAPIA POR MEDICAMENTOS Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Emiratos Árabes Unidos